DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

BioHarvest Sciences Inc.

CNSX:BHSC Stock Report

Market Cap: CA$137.8m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

BioHarvest Sciences Future Growth

Future criteria checks 5/6

BioHarvest Sciences is forecast to grow earnings and revenue by 63.4% and 32.9% per annum respectively.

Key information

63.4%

Earnings growth rate

n/a

EPS growth rate

Personal Products earnings growth27.5%
Revenue growth rate32.9%
Future return on equityn/a
Analyst coverage

Low

Last updated10 Jan 2025

Recent future growth updates

Recent updates

Analysis Article • Nov 17

Revenues Tell The Story For BioHarvest Sciences Inc. (CSE:BHSC) As Its Stock Soars 26%

BioHarvest Sciences Inc. ( CSE:BHSC ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Mar 17

BioHarvest Sciences Inc.'s (CSE:BHSC) P/S Is On The Mark

When you see that almost half of the companies in the Personal Products industry in Canada have price-to-sales ratios...
Analysis Article • Dec 01

Investors Interested In BioHarvest Sciences Inc.'s (CSE:BHSC) Revenues

BioHarvest Sciences Inc.'s ( CSE:BHSC ) price-to-sales (or "P/S") ratio of 6.5x may look like a poor investment...
Analysis Article • Jan 17

Don't Ignore The Fact That This Insider Just Sold Some Shares In BioHarvest Sciences Inc. (CSE:BHSC)

Some BioHarvest Sciences Inc. ( CSE:BHSC ) shareholders may be a little concerned to see that the Co-Founder, Zaki...
Analysis Article • Jan 10

How Much Of BioHarvest Sciences Inc. (CSE:BHSC) Do Insiders Own?

If you want to know who really controls BioHarvest Sciences Inc. ( CSE:BHSC ), then you'll have to look at the makeup...

Earnings and Revenue Growth Forecasts

CNSX:BHSC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2027868171
12/31/2026642-28-33
12/31/202541-4-1013
12/31/202425-13-2-63
9/30/202422-17-10-7N/A
6/30/202419-16-9-7N/A
3/31/202416-18-10-8N/A
12/31/202313-13-10-9N/A
9/30/202311-8-9-8N/A
6/30/20239-10-11-10N/A
3/31/20237-10-10-8N/A
12/31/20225-11-10-9N/A
9/30/20224-10-10-9N/A
6/30/20223-9-10-8N/A
3/31/20222-5-10-8N/A
12/31/20212-10-8-7N/A
9/30/20212-11-7-6N/A
6/30/20211-10-7-6N/A
3/31/20211-13-5-4N/A
12/31/20200-7-4-4N/A
9/30/20200-5-3-3N/A
6/30/20200-5-2-2N/A
3/31/20200-4-3-3N/A
12/31/20190-5-2-2N/A
9/30/20190-5-3-3N/A
12/31/20180-7-3-3N/A
12/31/20170-2N/A-2N/A
12/31/20160-3N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BHSC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).

Earnings vs Market: BHSC is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BHSC is expected to become profitable in the next 3 years.

Revenue vs Market: BHSC's revenue (32.9% per year) is forecast to grow faster than the Canadian market (5.3% per year).

High Growth Revenue: BHSC's revenue (32.9% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BHSC's Return on Equity is forecast to be high in 3 years time


Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/19 06:08
End of Day Share Price 2025/02/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioHarvest Sciences Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew HewittCraig-Hallum Capital Group LLC
Amit DayalH.C. Wainwright & Co.
Anthony VendettiMaxim Group

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide